We are live on ! Find out more
FBRX icon

Forte Biosciences
FBRX

62 hedge funds and large institutions have $273M invested in Forte Biosciences in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 7

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

27% more funds holding

Funds holding: 49 → 62 (+13)

0.26% less ownership

Funds ownership: 2.62% → 2.36% (-0.26%)

11% less capital invested

Capital invested by funds: $306M → $273M (-$32.5M)

Holders
62
Holders Change
+13
Holders Change %
+26.53%
% of All Funds
1.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
20
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$13.6M
2
PA
Perceptive Advisors
New York
+$11M
3
SCM
Suvretta Capital Management
New York
+$9.01M
4
ACM
Altium Capital Management
New York
+$4.41M
5
Millennium Management
Millennium Management
New York
+$3.99M

Top Sellers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
-$50.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$8.04M
3
Franklin Resources
Franklin Resources
California
-$7.49M
4
CS
Credit Suisse
Switzerland
-$3.1M
5
MS
Maven Securities
Jersey
-$3.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
$143K +$138K +168 New
Deutsche Bank
52
Deutsche Bank
Germany
$108K – – –
LC
53
Lindbrook Capital
California
$34K +$32.8K +40 New
TRCT
54
Tower Research Capital (TRC)
New York
$22K +$21.3K +26 New
JCM
55
Jacobi Capital Management
Pennsylvania
$15K – – –
Russell Investments Group
56
Russell Investments Group
United Kingdom
$15K +$14.7K +18 New
UBS Group
57
UBS Group
Switzerland
$10K -$13.1K -16 -57%
Osaic Holdings
58
Osaic Holdings
Arizona
$8K +$2.46K +3 +50%
MWP
59
Meridian Wealth Partners
Pennsylvania
$3K +$2.46K +3 New
Wells Fargo
60
Wells Fargo
California
$2K -$205K -250 -99%
Carson Wealth (CWM LLC)
61
Carson Wealth (CWM LLC)
Nebraska
$2K – – –
SFS
62
Sowell Financial Services
Arkansas
$1K +$819 +1 New
CS
63
Credit Suisse
Switzerland
– -$3.1M -3,406 Closed
MS
64
Maven Securities
Jersey
– -$3.04M -3,335 Closed
6CM
65
683 Capital Management
New York
– -$1.66M -1,825 Closed
Bank of New York Mellon
66
Bank of New York Mellon
New York
– -$213K -234 Closed
TFM
67
TFC Financial Management
Massachusetts
– -$18K -20 Closed
LWCFA
68
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
– -$7K -8 Closed
PGAM
69
Princeton Global Asset Management
New Jersey
– -$1K -1 Closed
1 2
3

FBRX Hedge Fund Activity: Q1 2021 in Review

62 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q1 2021, worth a combined $273M — down 11% from $306M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new FBRX positions and 7 closed out — a net gain of 13 holders — while 20 added to existing stakes and 12 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $13.6M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $50.5M.

  • 62 institutional investors held Forte Biosciences (FBRX) as of Q1 2021, up from 49 in Q4 2020.
  • Funds reported $273M of Forte Biosciences stock for Q1 2021, down 11% quarter-over-quarter.
  • 20 funds opened new Forte Biosciences positions in Q1 2021 and 7 closed out, a net change of +13 holders.
  • The largest Forte Biosciences buyer in Q1 2021 was Point72 Asset Management, an estimated $13.6M added.
  • The largest Forte Biosciences seller in Q1 2021 was ArrowMark Colorado Holdings, an estimated $50.5M sold.

Based on aggregated 13F filings for Q1 2021.